{"symbol":"ISRG","provider":"yahoo-finance","fetchedAt":"2025-12-25T09:27:37.445Z","asOfDate":"2025-12-25","articles":[{"id":"ea041153-2c88-30e9-bd27-64363ae019c3","title":"Reasons to Hold AngioDynamics Stock in Your Portfolio for Now","url":"https://finance.yahoo.com/news/reasons-hold-angiodynamics-stock-portfolio-172900370.html","publisher":"Zacks","publishedAt":"2025-12-24T17:29:00.000Z","relatedTickers":["ANGO","BSX","^GSPC"],"mainIdea":"Reasons to Hold AngioDynamics Stock in Your Portfolio for Now","summary":"Zacks: Reasons to Hold AngioDynamics Stock in Your Portfolio for Now. ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds. Related tickers mentioned: ANGO, BSX, ^GSPC."},{"id":"a3e6842a-94de-3d92-acc7-668e45921112","title":"This Medical Robotics Name Wins FDA Greenlight; Its Stock Nears A Buy Point","url":"https://finance.yahoo.com/m/a3e6842a-94de-3d92-acc7-668e45921112/this-medical-robotics-name.html","publisher":"Investor's Business Daily","publishedAt":"2025-12-24T15:01:29.000Z","relatedTickers":[],"mainIdea":"This Medical Robotics Name Wins FDA Greenlight; Its Stock Nears A Buy Point","summary":"Investor's Business Daily: This Medical Robotics Name Wins FDA Greenlight; Its Stock Nears A Buy Point. This medical robotics stock is hovering below an alternate entry. The FDA grants approval for new uses of its surgical system."},{"id":"9b8eca56-11b5-3e16-8afb-144e289a37e1","title":"Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?","url":"https://finance.yahoo.com/news/worth-investing-intuitive-surgical-isrg-143003051.html","publisher":"Zacks","publishedAt":"2025-12-24T14:30:03.000Z","relatedTickers":[],"mainIdea":"Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?","summary":"Zacks: Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?. The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?"}]}
